EAST LANSING, Mich. — Michigan State University researchers have created a new way to treat breast cancer. They developed light-sensitive chemicals, called cyanine-carborane salts, that are used in ...

Late stage pancreatic cancer benefits from photodynamic therapy (PDT) but the resources needed for the usual accompanying dosimetry present barriers, Dartmouth researchers Jonathan T. Elliott, PhD and ...

WOBURN, Mass., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of ...

WOBURN, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of ...

Immunohistochemistry-based molecular subtyping in muscle-invasive bladder cancer: Predicting response to neoadjuvant chemotherapy. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.

Innovation Center of NanoMedicine (iCONM), in collaboration with Prof. Takahiro Nomoto's Lab at the University of Tokyo, will hold a seminar on drug design and rationalization of treatment protocols ...

Study on prevention of recurrence in patients with NMIBC for whom BCG vaccine treatment failed by hematoporphyrin intravesical perfusion photodynamic therapy (PDT) combined with intravesical perfusion ...

WOBURN, Mass., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of ...